Núñez RM, Gutiérrez GD, Rivero VM, López ER, González NAM

Language: Spanish
References: 17
Page: 582-590
PDF size: 203.02 Kb.

ABSTRACT

Introduction: Early diagnosis of cervical cancer is a practice important to maintain health.
Objective: To identify the risk factors for cervical precursor lesions.
Methods: Observational case-control study of cases carried out at Manuel Piti Fajardo Polyclinic during 2015. The study population consisted of 46 women aged 25-59 years old and with altered Pap smear test results (study group), while, by simple random sampling, 46 women were selected at ages similar to those of the study and with negative Pap smear test results (control group). The information was obtained by conduction a survey and from the organic cytology cards. The percentage analysis, the arithmetic mean, and the chi-square test were used to determine associations between variables.
Results: In the study group, the smoking habit prevailed (73.91% with X²= 35.28); 60.87% had sexual intercourse before age 15 (X²= 26.67); the condom was used by 8.70% of the patients; 36.96% had more than four sexual partners, and 34.78% had human papilloma virus (X²= 134.08).
Conclusions: The risk factors for cervical precursor lesions identified were smoking, early start of sexual intercourse, not using a condom, having multiple sexual partners and having a history of sexually transmitted infections.

REFERENCES

1. García Rosique RM, Torres Triana A, Rendón Quintero M. Conocimientos sobre prevención del cáncer cérvicouterino en los adolescentes. Rev Méd Electrón. 2011 [citado 25 Mar 2016];33(2):[aprox. 5 p.]. Disponible en URL: http://www.revmatanzas.sld.cu/revista %20medica/ano %202011/vol2 %202011/tema09.htm

2. Baquedano ML, Lamarca BM, José GY, Rubio CP, Ruiz MÁ. Neoplasia vaginal intraepitelial. Rev. Chil. Obstet. Ginecol. 2013 [citado 25 Mar 2016];78(2):[aprox. 6 p.]. Disponible en: http://dx.doi.org/10.4067/S0717-75262013000200011

3. Ministerio de Salud Pública. Dirección nacional de estadística. Anuario Estadístico de Salud. La Habana: MINSAP; 2006.

4. Gungor T, Altinkaya SO, Ozat M, Akbay S, Mollamahmutoglu L. Unusual form of superficial spreading squamous cell carcinoma of cervix involving the endometrium, bilateral tubes and ovaries: a case report with literature review. Arch Gynecol Obstet. 2011;283(3):323-7.

5. Ishida M, Okabe H. Superficial spreading squamous cell carcinoma of the uterine cervix involving the endometrium: Report of two cases with emphasis on the likely molecular mechanism. Oncology Letters. 2015;5(1):31-4.

6. Guzmán P, Iriarte M. Carcinoma epidermoide de cuello uterino con extensión superficial a endometrio. Rev. chil. obstet. Inecol. 2016 [citado 25 Mar 2016];81(2):[aprox. 8 p.]. Disponible en: http://dx.doi.org/10.4067/S0717-75262016000200007

7. Bosch FX. The path to eliminate cervical cancer in the world and the challenges of professional education. Vaccine. 2013;31(Suppl 7):xi-xii.

8. Cordeiro G, Pérez S, Iñarrea A, Daniel Simón V, Reboredo C, Couceiro E, et al. ¿Por qué no se vacunan nuestras pacientes? Motivos por los que las pacientes fuera de los programas de vacunación sistemática, con infección por el virus del Papiloma Humano, deciden decir no a la vacuna. Rev Chil Obstet Ginecol. 2014 [citado 25 Mar 2016];79(5):[aprox. 9 p.]. Disponible en: http://dx.doi.org/10.4067/S0717-75262014000500006

9. Orlando G, Fasolo M, Mazza F, Ricci E, Esposito S, Frati E, et al. Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13-26 years) enrolled in the VALHIDATE study. Hum Vaccin Immunother. 2014 [citado 25 Mar 2016];10(4):986-94. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896517/

10. Wong LP. Knowledge and attitudes about HPV infection, HPV vaccination, and cervical cancer among rural Southeast Asian women. Int J Behav Med. 2011;18:105-11.

11. Basu P, Mittal S. Acceptability of human papillomavirus vaccine among the urban, affluent and educated parents of young girls residing in Kolkata, Eastern India. J Obstet Gynaecol Res. 2011;37:393-401.

12. Hopkins TG, Wood N. Female human papillomavirus (HPV) vaccination: Global uptake and the impact of attitudes. Vaccine. 2013;31:1673-9.

13. Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30:F123-F138.

14. Torné Bladé A, Bayas Rodríguez JM, Castellsagué Piqu X, Sánchez MC, García García E, Martínez Escoriza JC, et al. Vacunación frente al cáncer de cérvix en mujeres fuera de los programas de vacunación sistemática, con o sin infección por el virus del papiloma humano o lesión cervical. Encuesta de opinión y recomendaciones. Prog Obstet Ginecol. 2012;55(Suppl 1):10-31.

15. Yazigi R, Selman A, Puga O, Contreras L. Utilidad de la detección de virus papiloma de alto riesgo en pacientes con citología atípica y de neoplasia intraepitelial de bajo grado de cuello uterino. Rev Chil Obstet Ginecol. 2016 [citado 25 Mar 2016];81(1):[aprox. 7 p.]. Disponible en: http://dx.doi.org/10.4067/S0717-75262016000100005

16. Massad S, Einstein M, Huh W, Katki H. 2012 Updated Consensus Guidelines for the Management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121:829-45.

17. Ferreccio C, Barriga MI, Lagos M, Ibáñez C, Poggi H, González F, et al. Screening trial of human papilloma-virus for early detection in cervical cancer in Santiago, Chile. Int J Cancer. 2013;132:916-23.